FDA says Glaxo vaccine blocks cancer-causing virus
WASHINGTON (AP) -- The Food and Drug Administration says a vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer.
In documents posted online, the FDA says Cervarix -- Glaxo's vaccine against human papilloma virus or HPV -- successfully blocked the virus nearly 93 percent of the time. Side effects with the vaccine were mild, such as soreness at the injection site.
Are you a newspaper subscriber but you don't have a Digital Access account yet? https://secure.forumcomm.com/?publisher_ID=40&event=subscriber/lookup.
You will need your subscription account number and phone number. Not sure if you have an account? Email us at email@example.com and we can help you.